Trial Profile
Impact of replacing 5-fluorouracil (5-FU) with capecitabine in definitive chemoradiation for patients Undergoing Definitive Chemoradiation Using Intensity Modulated Radiation Therapy for Anal Cancer.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 06 Sep 2017
Price :
$35
*
At a glance
- Drugs Capecitabine (Primary) ; Mitomycin (Primary) ; Fluorouracil
- Indications Anal cancer; Squamous cell cancer
- Focus Adverse reactions
- 06 Sep 2017 New trial record
- 01 Aug 2017 Results published in the International Journal of Radiation Oncology, Biology, Physics